Skip to Content

Health Highlights: Oct. 16, 2012

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

More Hospitals Ban Free Infant Formula Samples

A nationwide effort to stop new mothers from receiving free infant formula samples appears to be having an effect.

In 2011, nearly half of about 2,600 hospitals in a survey by the U.S. Centers for Disease Control and Prevention said they no longer gave formula samples to breastfeeding mothers, up from one-quarter of hospitals in 2007. The survey did not ask about giving samples to non-nursing mothers, The New York Times reported.

The health authorities and breastfeeding advocates leading the effort to ban formula samples say the samples -- which often come in fashionable bags with infant formula company logos -- can lure women away from breastfeeding.

Their campaign is leading to changes. For example, all hospitals in Massachusetts and Rhode Island have halted free formula samples, and 24 hospitals in Oklahoma recently agreed to a ban, The Times reported.

Formula makers and some mothers say the samples are a healthy alternative that can provide relief if breastfeeding causes fatigue, pain or frustration. They dispute the charge that the samples can sway mothers from breastfeeding.

"We're not anti-formula," Dr. Melissa Bartick, a founder of Ban the Bags, a breast-feeding advocacy group, The Times reported. "If a woman makes an informed choice to formula-feed, the hospital should provide that formula. But hospitals shouldn't be marketing it."


Bra Device Detects Early Breast Cancer: Company

A U.S. company says it has created a bra device that can detect early signs of breast cancer.

The Breast Tissue Screening Bra can detect tumors before a self-test or mammogram would, according to First Warning Systems of Reno, Nev., CBS News reported.

A doctor would give the bra to a woman to wear for 12 hours. During that time, 16 temperature sensors in the cup would scan for deep tissue temperature changes that could indicate the growth of new blood vessels to feed a tumor. In addition, pattern recognition software would detect breast tissue irregularities.

In three clinical trials involving a total of 650 women, the bra was more than 90 percent accurate in detecting breast cancer, according to the company, CBS News reported.

The company plans to release the bra in Europe next year. Depending on FDA approval, it could be available in the U.S. as soon as 2014. The company didn't disclose the cost of the bra, but said each individual test will be about $25.


Nobel Economics Prize Awarded for Match-Making Research

The 2012 Nobel economics prize was awarded Monday to two American scholars for their research on match-making in markets where prices aren't the deciding factor, including pairing human organs with transplant recipients and student doctors with hospitals.

The recipients are Alvin Roth, 60, and Lloyd Shapley, 89. Roth is a professor at Harvard University and Harvard Business School. Shapley is a professor emeritus at the University of California, Los Angeles, the Associated Press reported.

"There are economic problems that can't be solved with normal market mechanisms," prize committee member Peter Gardenfors said. "With these matchings there is no money involved so the main thing is to follow what kind of preferences people have -- who wants to be matched with whom -- and find a good solution to that."

Along with the health-field applications, the work by Roth and Shapley can be used in a number of other areas, including matching students with schools and refugees with housing, the AP reported.


© 2018 HealthDay. All rights reserved.

Posted: October 2012